Esperienze con ciprofloxacina impiegata in terapia sequenziale nella riacutizzazione della bronchite cronica del paziente anziano ospedalizzato

Translated title of the contribution: Esperiences with Ciprofloxacin (sequential treatment) in exacerbation of chronic bronchitis in aged hospitalied patients

E. Bucchioni, G. Cavallaro, W. Fasano, G. Piatti

Research output: Contribution to journalArticle

Abstract

On 30 hospitalized, aged (>65 years old, mean age: 75,3) patients, both sexes, affected by acute exacerbation of chronic bronchitis (AECB), we have evaluated both clinically and microbiologically, the efficacy of ciprofloxacin "sequentially" administared (initial venous treatment followed by oral admi-nistration of the same drug). Ciprofloxacin has been given i.V., 200 mg twice-a-day for 5 days, followed by 5 more days of oral administration, 500 mg twice-a-day. Laboratory tests have been repeatedly performed, sputum bacteriology at T0, T4, T10 and T20 days. In the cultured 30 samples of sputum, 30 bacterial isolates were found which were considered responsible for the AECB: none of them was Ciprofloxacin-resistant. On the 4th day, 63,3% of the sputa resulted sterile; while Gram- pathogens were microbiologically all eradicated, the S.pneumoniae eradication was obtained only at the end of therapy. Total percentage of eradication, at the end of therapy was=86,6%, a result corresponding exactly to the clinical success/resolution of symptoms, the germs showed no resistance to Ciprofloxacin. Its "sequential" mode of use so represents a valuable indication for the treatment of AECB in the aged patients.

Original languageItalian
Pages (from-to)392-397
Number of pages6
JournalGIMT - Giornale Italiano delle Malattie del Torace
Volume56
Issue number5
Publication statusPublished - 2002

Fingerprint

Chronic Bronchitis
Ciprofloxacin
Sputum
Bacteriology
Therapeutics
Oral Administration
Pneumonia
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Esperienze con ciprofloxacina impiegata in terapia sequenziale nella riacutizzazione della bronchite cronica del paziente anziano ospedalizzato. / Bucchioni, E.; Cavallaro, G.; Fasano, W.; Piatti, G.

In: GIMT - Giornale Italiano delle Malattie del Torace, Vol. 56, No. 5, 2002, p. 392-397.

Research output: Contribution to journalArticle

@article{d3cb78a1e3aa4bdea3ed654724503ed8,
title = "Esperienze con ciprofloxacina impiegata in terapia sequenziale nella riacutizzazione della bronchite cronica del paziente anziano ospedalizzato",
abstract = "On 30 hospitalized, aged (>65 years old, mean age: 75,3) patients, both sexes, affected by acute exacerbation of chronic bronchitis (AECB), we have evaluated both clinically and microbiologically, the efficacy of ciprofloxacin {"}sequentially{"} administared (initial venous treatment followed by oral admi-nistration of the same drug). Ciprofloxacin has been given i.V., 200 mg twice-a-day for 5 days, followed by 5 more days of oral administration, 500 mg twice-a-day. Laboratory tests have been repeatedly performed, sputum bacteriology at T0, T4, T10 and T20 days. In the cultured 30 samples of sputum, 30 bacterial isolates were found which were considered responsible for the AECB: none of them was Ciprofloxacin-resistant. On the 4th day, 63,3{\%} of the sputa resulted sterile; while Gram- pathogens were microbiologically all eradicated, the S.pneumoniae eradication was obtained only at the end of therapy. Total percentage of eradication, at the end of therapy was=86,6{\%}, a result corresponding exactly to the clinical success/resolution of symptoms, the germs showed no resistance to Ciprofloxacin. Its {"}sequential{"} mode of use so represents a valuable indication for the treatment of AECB in the aged patients.",
keywords = "Acute exacerbations, Cgronic bronchitis, Ciprofloxacin, Sequential treatment aged patients",
author = "E. Bucchioni and G. Cavallaro and W. Fasano and G. Piatti",
year = "2002",
language = "Italian",
volume = "56",
pages = "392--397",
journal = "GIMT - Giornale Italiano delle Malattie del Torace",
issn = "1127-0810",
publisher = "Giornale Italiano Delle Malattie del Torace",
number = "5",

}

TY - JOUR

T1 - Esperienze con ciprofloxacina impiegata in terapia sequenziale nella riacutizzazione della bronchite cronica del paziente anziano ospedalizzato

AU - Bucchioni, E.

AU - Cavallaro, G.

AU - Fasano, W.

AU - Piatti, G.

PY - 2002

Y1 - 2002

N2 - On 30 hospitalized, aged (>65 years old, mean age: 75,3) patients, both sexes, affected by acute exacerbation of chronic bronchitis (AECB), we have evaluated both clinically and microbiologically, the efficacy of ciprofloxacin "sequentially" administared (initial venous treatment followed by oral admi-nistration of the same drug). Ciprofloxacin has been given i.V., 200 mg twice-a-day for 5 days, followed by 5 more days of oral administration, 500 mg twice-a-day. Laboratory tests have been repeatedly performed, sputum bacteriology at T0, T4, T10 and T20 days. In the cultured 30 samples of sputum, 30 bacterial isolates were found which were considered responsible for the AECB: none of them was Ciprofloxacin-resistant. On the 4th day, 63,3% of the sputa resulted sterile; while Gram- pathogens were microbiologically all eradicated, the S.pneumoniae eradication was obtained only at the end of therapy. Total percentage of eradication, at the end of therapy was=86,6%, a result corresponding exactly to the clinical success/resolution of symptoms, the germs showed no resistance to Ciprofloxacin. Its "sequential" mode of use so represents a valuable indication for the treatment of AECB in the aged patients.

AB - On 30 hospitalized, aged (>65 years old, mean age: 75,3) patients, both sexes, affected by acute exacerbation of chronic bronchitis (AECB), we have evaluated both clinically and microbiologically, the efficacy of ciprofloxacin "sequentially" administared (initial venous treatment followed by oral admi-nistration of the same drug). Ciprofloxacin has been given i.V., 200 mg twice-a-day for 5 days, followed by 5 more days of oral administration, 500 mg twice-a-day. Laboratory tests have been repeatedly performed, sputum bacteriology at T0, T4, T10 and T20 days. In the cultured 30 samples of sputum, 30 bacterial isolates were found which were considered responsible for the AECB: none of them was Ciprofloxacin-resistant. On the 4th day, 63,3% of the sputa resulted sterile; while Gram- pathogens were microbiologically all eradicated, the S.pneumoniae eradication was obtained only at the end of therapy. Total percentage of eradication, at the end of therapy was=86,6%, a result corresponding exactly to the clinical success/resolution of symptoms, the germs showed no resistance to Ciprofloxacin. Its "sequential" mode of use so represents a valuable indication for the treatment of AECB in the aged patients.

KW - Acute exacerbations

KW - Cgronic bronchitis

KW - Ciprofloxacin

KW - Sequential treatment aged patients

UR - http://www.scopus.com/inward/record.url?scp=41149124593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41149124593&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:41149124593

VL - 56

SP - 392

EP - 397

JO - GIMT - Giornale Italiano delle Malattie del Torace

JF - GIMT - Giornale Italiano delle Malattie del Torace

SN - 1127-0810

IS - 5

ER -